Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calypte's oral HIV test:

This article was originally published in Clinica

Executive Summary

The Chinese state Food and Drug Administration (SFDA) has approved Calypte Biomedical's Aware HIV-1/2-OMT rapid oral HIV test. It is the first and only rapid oral fluid HIV diagnostic in the country, the Portland, Oregon-based company claimed. The product will be manufactured and sold by the firm's Chinese subsidiary, Beijing Marr Bio-Pharmaceutical. Calypte said it was "thrilled" with the long-awaited approval - it had originally hoped for a response from the Chinese FDA in mid-2005. HIV incidence in China is rising rapidly, and is expected to reach 15 million by 2010, the firm said. Aware was also approved in India in July 2007 (see Clinica No 1265, p 16).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel